Myeloid sarcoma in a one-month-old infant

Chihiro Wakusawa1, Taku Fujimura, Akira Hashimoto

  • 1Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Case Reports in Dermatology
|November 24, 2011
PubMed

Insights

Congenital myeloid sarcoma, a rare leukemia manifestation, presented as a skin lesion in an infant without systemic leukemia. Prompt chemotherapy resolved the lesion, with no recurrence for 1.5 years.

Area of Science:

  • Hematology
  • Pediatric Oncology
  • Dermatology

Background:

  • Myeloid sarcoma is a rare extramedullary tumor of myeloid blasts.
  • It can be associated with systemic leukemia or occur in isolation.
  • Congenital myeloid sarcoma is exceptionally rare, particularly without overt signs of leukemia.

Observation:

  • A 1-month-old infant presented with a bruise-like skin plaque.
  • Histopathology revealed atypical large lymphocytes (CD4+, CD56-, CD68+) in the dermis and subcutaneous tissue.
  • Bone marrow biopsy showed minimal blast cells (3.4%) with mixed-lineage leukemia gene abnormality.

Findings:

  • The infant was diagnosed with myeloid sarcoma not meeting criteria for systemic leukemia.
  • Skin lesions resolved within 10 days of chemotherapy.
  • No recurrence was observed for 1.5 years post-treatment.

Implications:

  • This case highlights congenital myeloid sarcoma as a distinct entity presenting primarily with cutaneous manifestations.
  • Early diagnosis and treatment can lead to favorable outcomes, even in the absence of systemic leukemia.
  • Further research into the unique biology and treatment of isolated congenital myeloid sarcoma is warranted.